Press release archive 2008

  • Alliance Boots completes acquisition of Depolabo

    Alliance Boots, a leading international pharmacy-led health and beauty group, announces the completion of its acquisition of Depolabo, one of the largest providers of pharmaceutical pre-wholesale and contract logistics services in France.

    02 December 2008
  • Alliance Boots Holdings Limited 28 Nov 2008

    This announcement has been made for regulatory purposes. It does not constitute a statement regarding the Group's financial or trading position.

    28 November 2008
  • Success of Alphega Pharmacy European Convention

    Alphega Pharmacy, the network of independent pharmacists sponsored by the Pharmaceutical Wholesale Division of Alliance Boots, recently held its annual European Convention

    18 November 2008
  • Alliance Boots mid-year update

    Following the publication in June of the 2007/08 Annual Review for the year ended 31 March 2008, Alliance Boots today provides a mid-year update.

    30 October 2008
  • Alliance Boots acquires megapharm in Germany

    Alliance Boots has today acquired a 90% stake in megapharm GmbH, a specialised German distributor of oncology products.

    16 October 2008
  • European Pharmacists Forum elects new President

    European pharmacists meeting at the third 2008 seminar of the European Pharmacists Forum (EPF) which took place on 9 and 10 October in Lisbon, Portugal, have elected Joao Silveira as the new President of EPF.

    10 October 2008
  • Alliance Boots to acquire Depolabo

    Alliance Boots, a leading international pharmacy-led health and beauty group, announces today that it has signed an agreement to acquire Depolabo

    06 October 2008
  • Alliance Boots publishes its 2007/08 Corporate Social Responsibility Report

    Alliance Boots is delighted to announce the publication of its 2007/08 Corporate Social Responsibility (CSR) Report for the year ended 31 March 2008.

    30 September 2008
  • Alliance Boots to enter Brazil

    Alliance Boots, a leading international pharmacy-led health & beauty group, announces today that it has signed an agreement to enter the Brazilian pharmaceutical wholesale market

    04 August 2008
  • Alliance Boots Holdings Limited

    This announcement has been made for regulatory purposes. It does not constitute a statement regarding the Group's financial or trading position.

    31 July 2008
  • Response to Moody's announcement

    Alliance Boots notes today's announcement by Moody's Investors Service Limited lowering the corporate family rating of the Group from B1 to B2 and its rating of Alliance Boots' £315m of public debt...

    09 July 2008
  • Alphega Pharmacy Membership Exceeds 1,000

    Alliance Boots is pleased to announce that Alphega Pharmacy, the virtual pharmacy network of its Pharmaceutical Wholesale Division (Alliance Healthcare), has increased its membership to more than 1,000 members across many European countries following a recent recruitment campaign.

    07 July 2008
  • 2007/08 Annual Review

    Alliance Boots, the pharmacy-led health and beauty group, has today published its 2007/08 Annual Review and Consolidated Financial Statements for the period ended 31 March 2008.

    10 June 2008
  • ALLIANCE BOOTS SUPPORTS PHARMACY EDUCATION

    Alliance Boots signed a cooperation agreement in Rome today, with the University of Tor Vergata in Rome and the University of Nottingham, to support a new pharmacy degree course with a strong international focus and a modern understanding of the profession.

    13 March 2008
  • ALLIANCE BOOTS CELEBRATES LAUNCH

    To mark the formation of the 50:50 joint venture between Alliance Boots and its Chinese partner Guangzhou Pharmaceutical Company Ltd (GPC Ltd), in Guangzhou Pharmaceuticals Corporation ("GP Corp"), a two-day celebratory opening ceremony was held on 26 and 27 February 2008 in Guangzhou, China.

    26 February 2008
  • ALLIANCE BOOTS COMPLETES JOINT VENTURE IN CHINA

    Following receipt of final government and regulatory approvals, Alliance Boots announces completion of the formation of its 50:50 joint venture company, Guangzhou Pharmaceuticals Corporation ("GP Corp") for a total consideration of approximately £41 million.

    29 January 2008